Indaptus Therapeutics Files 8-K on Equity Sales & Shareholder Votes
Ticker: INDP · Form: 8-K · Filed: Jul 29, 2025 · CIK: 1857044
| Field | Detail |
|---|---|
| Company | Indaptus Therapeutics, INC. (INDP) |
| Form Type | 8-K |
| Filed Date | Jul 29, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: equity-sale, shareholder-vote, corporate-action
TL;DR
Indaptus Therapeutics filed an 8-K for unregistered equity sales and shareholder votes.
AI Summary
Indaptus Therapeutics, Inc. filed an 8-K on July 29, 2025, reporting unregistered sales of equity securities and submission of matters to a vote of security holders as of July 25, 2025. The company, formerly known as Intec Parent Inc., is incorporated in Delaware and headquartered in New York.
Why It Matters
This filing indicates potential new equity issuance and upcoming shareholder decisions, which could impact the company's capital structure and strategic direction.
Risk Assessment
Risk Level: medium — Unregistered equity sales can sometimes signal financing needs or dilution, while shareholder votes can indicate significant corporate actions.
Key Players & Entities
- Indaptus Therapeutics, Inc. (company) — Registrant
- Intec Parent Inc. (company) — Former company name
- July 25, 2025 (date) — Date of earliest event reported
- July 29, 2025 (date) — Date of report
- 3 Columbus Circle (address) — Principal executive offices
FAQ
What type of equity securities were sold unregistered?
The filing does not specify the type of equity securities sold unregistered, only that such sales occurred.
What matters were submitted to a vote of security holders?
The filing indicates that matters were submitted to a vote of security holders, but does not detail what those specific matters were.
When was the earliest event reported in this 8-K?
The earliest event reported in this 8-K was on July 25, 2025.
What is Indaptus Therapeutics, Inc.'s former company name?
Indaptus Therapeutics, Inc.'s former company name was Intec Parent Inc.
Where are Indaptus Therapeutics, Inc.'s principal executive offices located?
Indaptus Therapeutics, Inc.'s principal executive offices are located at 3 Columbus Circle, 15th Floor, New York, New York 10019.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on July 29, 2025 regarding Indaptus Therapeutics, Inc. (INDP).